Caplin Point Laboratories Limited

NSEI:CAPLIPOINT Stock Report

Market Cap: ₹112.2b

Caplin Point Laboratories Dividend

Dividend criteria checks 5/6

Caplin Point Laboratories is a dividend paying company with a current yield of 0.34% that is well covered by earnings.

Key information

0.3%

Dividend yield

9%

Payout ratio

Industry average yield0.8%
Next dividend pay daten/a
Ex dividend daten/a
Dividend per sharen/a
Earnings per share₹60.13
Dividend yield forecast in 3Y0.2%

Recent dividend updates

Caplin Point Laboratories (NSE:CAPLIPOINT) Will Pay A Larger Dividend Than Last Year At ₹2.50

Aug 11
Caplin Point Laboratories (NSE:CAPLIPOINT) Will Pay A Larger Dividend Than Last Year At ₹2.50

Recent updates

Caplin Point Laboratories (NSE:CAPLIPOINT) Strong Profits May Be Masking Some Underlying Issues

May 24
Caplin Point Laboratories (NSE:CAPLIPOINT) Strong Profits May Be Masking Some Underlying Issues

Does Caplin Point Laboratories (NSE:CAPLIPOINT) Deserve A Spot On Your Watchlist?

May 04
Does Caplin Point Laboratories (NSE:CAPLIPOINT) Deserve A Spot On Your Watchlist?

Caplin Point Laboratories Limited's (NSE:CAPLIPOINT) Low P/E No Reason For Excitement

Mar 07
Caplin Point Laboratories Limited's (NSE:CAPLIPOINT) Low P/E No Reason For Excitement

With EPS Growth And More, Caplin Point Laboratories (NSE:CAPLIPOINT) Makes An Interesting Case

Oct 24
With EPS Growth And More, Caplin Point Laboratories (NSE:CAPLIPOINT) Makes An Interesting Case

Why We Think The CEO Of Caplin Point Laboratories Limited (NSE:CAPLIPOINT) May Soon See A Pay Rise

Sep 15
Why We Think The CEO Of Caplin Point Laboratories Limited (NSE:CAPLIPOINT) May Soon See A Pay Rise

Caplin Point Laboratories (NSE:CAPLIPOINT) Will Pay A Larger Dividend Than Last Year At ₹2.50

Aug 11
Caplin Point Laboratories (NSE:CAPLIPOINT) Will Pay A Larger Dividend Than Last Year At ₹2.50

We Discuss Whether Caplin Point Laboratories Limited's (NSE:CAPLIPOINT) CEO Is Due For A Pay Rise

Sep 23
We Discuss Whether Caplin Point Laboratories Limited's (NSE:CAPLIPOINT) CEO Is Due For A Pay Rise

Caplin Point Laboratories' (NSE:CAPLIPOINT) Shareholders Will Receive A Bigger Dividend Than Last Year

Sep 11
Caplin Point Laboratories' (NSE:CAPLIPOINT) Shareholders Will Receive A Bigger Dividend Than Last Year

Is Now The Time To Put Caplin Point Laboratories (NSE:CAPLIPOINT) On Your Watchlist?

Jul 22
Is Now The Time To Put Caplin Point Laboratories (NSE:CAPLIPOINT) On Your Watchlist?

Caplin Point Laboratories (NSE:CAPLIPOINT) Is Increasing Its Dividend To ₹2.00

May 15
Caplin Point Laboratories (NSE:CAPLIPOINT) Is Increasing Its Dividend To ₹2.00

A Look At The Intrinsic Value Of Caplin Point Laboratories Limited (NSE:CAPLIPOINT)

Jan 21
A Look At The Intrinsic Value Of Caplin Point Laboratories Limited (NSE:CAPLIPOINT)

Should You Be Adding Caplin Point Laboratories (NSE:CAPLIPOINT) To Your Watchlist Today?

Oct 20
Should You Be Adding Caplin Point Laboratories (NSE:CAPLIPOINT) To Your Watchlist Today?

Caplin Point Laboratories (NSE:CAPLIPOINT) Is Increasing Its Dividend To ₹1.50

Sep 17
Caplin Point Laboratories (NSE:CAPLIPOINT) Is Increasing Its Dividend To ₹1.50

Caplin Point Laboratories (NSE:CAPLIPOINT) Will Pay A Larger Dividend Than Last Year At ₹1.50

Sep 03
Caplin Point Laboratories (NSE:CAPLIPOINT) Will Pay A Larger Dividend Than Last Year At ₹1.50

Caplin Point Laboratories Limited's (NSE:CAPLIPOINT) Intrinsic Value Is Potentially 28% Above Its Share Price

Aug 27
Caplin Point Laboratories Limited's (NSE:CAPLIPOINT) Intrinsic Value Is Potentially 28% Above Its Share Price

Is Caplin Point Laboratories (NSE:CAPLIPOINT) A Risky Investment?

Jun 12
Is Caplin Point Laboratories (NSE:CAPLIPOINT) A Risky Investment?

Estimating The Fair Value Of Caplin Point Laboratories Limited (NSE:CAPLIPOINT)

Apr 29
Estimating The Fair Value Of Caplin Point Laboratories Limited (NSE:CAPLIPOINT)

Does Caplin Point Laboratories Limited (NSE:CAPLIPOINT) Have A Place In Your Dividend Portfolio?

Mar 24
Does Caplin Point Laboratories Limited (NSE:CAPLIPOINT) Have A Place In Your Dividend Portfolio?

We Think Caplin Point Laboratories (NSE:CAPLIPOINT) Can Stay On Top Of Its Debt

Mar 11
We Think Caplin Point Laboratories (NSE:CAPLIPOINT) Can Stay On Top Of Its Debt

Do Caplin Point Laboratories's (NSE:CAPLIPOINT) Earnings Warrant Your Attention?

Feb 26
Do Caplin Point Laboratories's (NSE:CAPLIPOINT) Earnings Warrant Your Attention?

What We Learned About Caplin Point Laboratories' (NSE:CAPLIPOINT) CEO Pay

Feb 14
What We Learned About Caplin Point Laboratories' (NSE:CAPLIPOINT) CEO Pay

Caplin Point Laboratories Limited's (NSE:CAPLIPOINT) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

Feb 02
Caplin Point Laboratories Limited's (NSE:CAPLIPOINT) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

Can You Imagine How Jubilant Caplin Point Laboratories' (NSE:CAPLIPOINT) Shareholders Feel About Its 105% Share Price Gain?

Jan 21
Can You Imagine How Jubilant Caplin Point Laboratories' (NSE:CAPLIPOINT) Shareholders Feel About Its 105% Share Price Gain?

Does This Valuation Of Caplin Point Laboratories Limited (NSE:CAPLIPOINT) Imply Investors Are Overpaying?

Jan 09
Does This Valuation Of Caplin Point Laboratories Limited (NSE:CAPLIPOINT) Imply Investors Are Overpaying?

Could The Caplin Point Laboratories Limited (NSE:CAPLIPOINT) Ownership Structure Tell Us Something Useful?

Dec 28
Could The Caplin Point Laboratories Limited (NSE:CAPLIPOINT) Ownership Structure Tell Us Something Useful?

Is It Worth Buying Caplin Point Laboratories Limited (NSE:CAPLIPOINT) For Its 0.5% Dividend Yield?

Dec 16
Is It Worth Buying Caplin Point Laboratories Limited (NSE:CAPLIPOINT) For Its 0.5% Dividend Yield?

We Think Caplin Point Laboratories (NSE:CAPLIPOINT) Can Stay On Top Of Its Debt

Dec 04
We Think Caplin Point Laboratories (NSE:CAPLIPOINT) Can Stay On Top Of Its Debt

Should You Be Adding Caplin Point Laboratories (NSE:CAPLIPOINT) To Your Watchlist Today?

Nov 21
Should You Be Adding Caplin Point Laboratories (NSE:CAPLIPOINT) To Your Watchlist Today?

Here's What We Learned About The CEO Pay At Caplin Point Laboratories Limited (NSE:CAPLIPOINT)

Nov 08
Here's What We Learned About The CEO Pay At Caplin Point Laboratories Limited (NSE:CAPLIPOINT)

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: CAPLIPOINT's dividends per share have been stable in the past 10 years.

Growing Dividend: CAPLIPOINT's dividend payments have increased over the past 10 years.


Dividend Yield vs Market

Caplin Point Laboratories Dividend Yield vs Market
How does CAPLIPOINT dividend yield compare to the market?
SegmentDividend Yield
Company (CAPLIPOINT)0.3%
Market Bottom 25% (IN)0.3%
Market Top 25% (IN)1.1%
Industry Average (Pharmaceuticals)0.8%
Analyst forecast in 3 Years (CAPLIPOINT)0.2%

Notable Dividend: CAPLIPOINT's dividend (0.34%) is higher than the bottom 25% of dividend payers in the Indian market (0.27%).

High Dividend: CAPLIPOINT's dividend (0.34%) is low compared to the top 25% of dividend payers in the Indian market (1.12%).


Earnings Payout to Shareholders

Earnings Coverage: With its low payout ratio (8.7%), CAPLIPOINT's dividend payments are thoroughly covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: With its low cash payout ratio (22%), CAPLIPOINT's dividend payments are well covered by cash flows.


Discover strong dividend paying companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.